RxDoctor Payments Data

Collene Greco

Adult Health · Huntington Station, NYNPI 1154422624

Payments from drug & device makers

$919in general payments, 2019–2025

Across 23 payments — averaging $39.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$165
  • AbbVie$125
  • GSK$124
  • Abbott$116
  • LEO Pharma Inc.$104
  • Johnson & Johnson$80
  • plus $205 from 7 others

What the payments were for

  • Food & beverage$919100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$919 in reported general payments places this provider in the 65th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$132,632
Medicare patients
722
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab13$84,652
Dupixent PenDupilumab17$61,223
OzempicSemaglutide11$13,621
LinzessLinaclotide11$5,841
Ketoconazole151$3,268
Metronidazole42$2,433
SynthroidLevothyroxine Sodium32$2,128
Betamethasone Dipropionate47$1,829
Solifenacin Succinate12$1,772
Fluorouracil29$1,726
Levothyroxine Sodium181$1,697
Atorvastatin Calcium198$1,571
Metoprolol Succinate111$1,506
Amlodipine Besylate171$1,203
Irbesartan37$1,164

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Synthroid$125$7,96943 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,828 adult health providers in New York.

Other adult health in Huntington Station

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →